Viral myocarditis in childhood

Paediatrics and Child Health

Volumn 17, Issue 1, 2007, Pages 11-18

  Kaski, Juan Pablo ^a   Burch, Michael ^a  

^a NONE

Author keywords

adenovirus; cardiomyopathy; enterovirus; myocarditis

Indexed keywords

ARTICLE; CARDIOLOGIST; CHILD; CHILDHOOD DISEASE; CLINICAL FEATURE; COLLAPSE; ECG ABNORMALITY; GENERAL PRACTITIONER; HEART FAILURE; HUMAN; IMMUNOMODULATION; PEDIATRICIAN; VIRUS MYOCARDITIS;

EID: 33947219499     PISSN: 17517222     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.paed.2006.12.003     Document Type: Article

References (86)

1. Harvey W.P. Clinical recognition and treatment of primary myocardial disease. Introduction. Circulation 32 (1965) 828-829
2. Mattingly T.W. Changing concepts of myocardial diseases. JAMA 191 (1965) 33-37
3. Feldman A.M., and McNamara D. Myocarditis. N Engl J Med 343 (2000) 1388-1398
4. Magnani J.W., and Dec G.W. Myocarditis: current trends in diagnosis and treatment. Circulation 113 (2006) 876-890
5. Aretz H.T., Billingham M.E., Edwards W.D., et al. Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol 1 (1987) 3-14
6. Shanes J.G., Ghali J., Billingham M.E., et al. Interobserver variability in the pathologic interpretation of endomyocardial biopsy results. Circulation 75 (1987) 401-405
7. Doolan A., Langlois N., and Semsarian C. Causes of sudden cardiac death in young Australians. Med J Aust 180 (2004) 110-112
8. Drory Y., Turetz Y., Hiss Y., et al. Sudden unexpected death in persons less than 40 years of age. Am J Cardiol 68 (1991) 1388-1392
9. Fabre A., and Sheppard M.N. Sudden adult death syndrome and other non-ischaemic causes of sudden cardiac death. Heart 92 (2006) 316-320
10. Phillips M., Robinowitz M., Higgins J.R., et al. Sudden cardiac death in Air Force recruits. A 20-year review. JAMA 256 (1986) 2696-2699
11. Wesslen L., Pahlson C., Lindquist O., et al. An increase in sudden unexpected cardiac deaths among young Swedish orienteers during 1979-1992. Eur Heart J 17 (1996) 902-910
12. Kleinert S., Weintraub R.G., Wilkinson J.L., et al. Myocarditis in children with dilated cardiomyopathy: incidence and outcome after dual therapy immunosuppression. J Heart Lung Transplant 16 (1997) 1248-1254
13. Florian S.F., Gomez N.C., Castrillo G.N., et al. [Chagasic cardiomyopathy in Spain: a diagnosis to bear in mind]. Ann Med Interne 22 (2005) 538-540
14. Hagar J.M., and Rahimtoola S.H. Chagas' heart disease in the United States. N Engl J Med 325 (1991) 763-768
15. Sztajzel J., Cox J., Pache J.C., et al. Chagas' disease may also be encountered in Europe. Eur Heart J 17 (1996) 1289
16. Baboonian C., and McKenna W. Eradication of viral myocarditis: is there hope?. J Am Coll Cardiol 42 (2003) 473-476
17. Dunn J.J., Chapman N.M., Tracy S., et al. Genomic determinants of cardiovirulence in coxsackievirus B3 clinical isolates: localization to the 5' nontranslated region. J Virol 74 (2000) 4787-4794
18. Cambridge G., MacArthur C.G., Waterson A.P., et al. Antibodies to Coxsackie B viruses in congestive cardiomyopathy. Br Heart J 41 (1979) 692-696
19. Griffiths P.D., Hannington G., and Booth J.C. Coxsackie B virus infections and myocardial infarction. Results from a prospective, epidemiologically controlled study. Lancet 1 (1980) 1387-1389
20. Bowles N.E., Richardson P.J., Olsen E.G., et al. Detection of Coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet 1 (1986) 1120-1123
21. Badorff C., Lee G.H., Lamphear B.J., et al. Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat Med 5 (1999) 320-326
22. Lonberg-Holm K., Crowell R.L., and Philipson L. Unrelated animal viruses share receptors. Nature 259 (1976) 679-681
23. Roelvink P.W., Lizonova A., Lee J.G., et al. The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F. J Virol 72 (1998) 7909-7915
24. Berkovich S., Rodriguez-Torres R., and Lin J.S. Virologic studies in children with acute myocarditis. Am J Dis Child 115 (1968) 207-212
25. Akhtar N., Ni J., Stromberg D., et al. Tracheal aspirate as a substrate for polymerase chain reaction detection of viral genome in childhood pneumonia and myocarditis. Circulation 99 (1999) 2011-2018
26. Calabrese F., and Thiene G. Myocarditis and inflammatory cardiomyopathy: microbiological and molecular biological aspects. Cardiovasc Res 60 (2003) 11-25
27. Martin A.B., Webber S., Fricker F.J., et al. Acute myocarditis. Rapid diagnosis by PCR in children. Circulation 90 (1994) 330-339
28. Shimizu C., Rambaud C., Cheron G., et al. Molecular identification of viruses in sudden infant death associated with myocarditis and pericarditis. Pediatr Infect Dis J 14 (1995) 584-588
29. Bowles N.E., Ni J., Kearney D.L., et al. Detection of viruses in myocardial tissues by polymerase chain reaction. evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol 42 (2003) 466-472
30. Klein R.M., Jiang H., Niederacher D., et al. Frequency and quantity of the parvovirus B19 genome in endomyocardial biopsies from patients with suspected myocarditis or idiopathic left ventricular dysfunction. Z Kardiol 93 (2004) 300-309
31. Munro K., Croxson M.C., Thomas S., et al. Three cases of myocarditis in childhood associated with human parvovirus (B19 virus). Pediatr Cardiol 24 (2003) 473-475
32. Zack F., Klingel K., Kandolf R., et al. Sudden cardiac death in a 5-year-old girl associated with parvovirus B19 infection. Forensic Sci Int 155 (2005) 13-17
33. Dettmeyer R., Kandolf R., Baasner A., et al. Fatal parvovirus B19 myocarditis in an 8-year-old boy. J Forensic Sci 48 (2003) 183-186
34. Murry C.E., Jerome K.R., and Reichenbach D.D. Fatal parvovirus myocarditis in a 5-year-old girl. Hum Pathol 32 (2001) 342-345
35. Rohayem J., Dinger J., Fischer R., et al. Fatal myocarditis associated with acute parvovirus B19 and human herpesvirus 6 coinfection. J Clin Microbiol 39 (2001) 4585-4587
36. Hofman P., Drici M.D., Gibelin P., et al. Prevalence of toxoplasma myocarditis in patients with the acquired immunodeficiency syndrome. Br Heart J 70 (1993) 376-381
37. Herskowitz A., Wu T.C., Willoughby S.B., et al. Myocarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late-stage infection with human immunodeficiency virus. J Am Coll Cardiol 24 (1994) 1025-1032
38. Barbaro G., Di L.G., Grisorio B., et al. Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients. Gruppo Italiano per lo Studio Cardiologico dei Pazienti Affetti da AIDS. N Engl J Med 339 (1998) 1093-1099
39. Mason J.W. Myocarditis and dilated cardiomyopathy: an inflammatory link. Cardiovasc Res 60 (2003) 5-10
40. Liu P.P., and Mason J.W. Advances in the understanding of myocarditis. Circulation 104 (2001) 1076-1082
41. Mason J.W., O'Connell J.B., Herskowitz A., et al. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 333 (1995) 269-275
42. English R.F., Janosky J.E., Ettedgui J.A., et al. Outcomes for children with acute myocarditis. Cardiol Young 14 (2004) 488-493
43. Lee K.J., McCrindle B.W., Bohn D.J., et al. Clinical outcomes of acute myocarditis in childhood. Heart 82 (1999) 226-233
44. Angelini A., Calzolari V., Calabrese F., et al. Myocarditis mimicking acute myocardial infarction: role of endomyocardial biopsy in the differential diagnosis. Heart 84 (2000) 245-250
45. Dec Jr. G.W., Waldman H., Southern J., et al. Viral myocarditis mimicking acute myocardial infarction. J Am Coll Cardiol 20 (1992) 85-89
46. Dec Jr. G.W., Palacios I.F., Fallon J.T., et al. Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome. N Engl J Med 312 (1985) 885-890
47. Felker G.M., Thompson R.E., Hare J.M., et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 342 (2000) 1077-1084
48. Herskowitz A., Campbell S., Deckers J., et al. Demographic features and prevalence of idiopathic myocarditis in patients undergoing endomyocardial biopsy. Am J Cardiol 71 (1993) 982-986
49. Gagliardi M.G., Bevilacqua M., Bassano C., et al. Long term follow up of children with myocarditis treated by immunosuppression and of children with dilated cardiomyopathy. Heart 90 (2004) 1167-1171
50. Baasner A., Dettmeyer R., Graebe M., et al. PCR-based diagnosis of enterovirus and parvovirus B19 in paraffin-embedded heart tissue of children with suspected sudden infant death syndrome. Lab Invest 83 (2003) 1451-1455
51. Greenwood R.D., Nadas A.S., and Fyler D.C. The clinical course of primary myocardial disease in infants and children. Am Heart J 92 (1976) 549-560
52. Gagliardi M.G., Bevilacqua M., Squitieri C., et al. Dilated cardiomyopathy caused by acute myocarditis in pediatric patients: evolution of myocardial damage in a group of potential heart transplant candidates. J Heart Lung Transplant 12 (1993) S224-S229
53. Inwald D., Franklin O., Cubitt D., et al. Enterovirus myocarditis as a cause of neonatal collapse. Arch Dis Child Fetal Neonatal Ed 89 (2004) F461-F462
54. Levi D., and Alejos J. Diagnosis and treatment of pediatric viral myocarditis. Curr Opin Cardiol 16 (2001) 77-83
55. Pinamonti B., Alberti E., Cigalotto A., et al. Echocardiographic findings in myocarditis. Am J Cardiol 62 (1988) 285-291
56. Friedrich M.G., Strohm O., Schulz-Menger J., et al. Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation 97 (1998) 1802-1809
57. Lauer B., Niederau C., Kuhl U., et al. Cardiac troponin T in patients with clinically suspected myocarditis. J Am Coll Cardiol 30 (1997) 1354-1359
58. Smith S.C., Ladenson J.H., Mason J.W., et al. Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. Circulation 95 (1997) 163-168
59. Baughman K.L. Diagnosis of myocarditis: death of Dallas criteria. Circulation 113 (2006) 593-595
60. Caforio A.L., Goldman J.H., Baig M.K., et al. Cardiac autoantibodies in dilated cardiomyopathy become undetectable with disease progression. Heart 77 (1997) 62-67
61. Fowles R.E., and Mason J.W. Role of cardiac biopsy in the diagnosis and management of cardiac disease. Prog Cardiovasc Dis 27 (1984) 153-172
62. Parrillo J.E., Aretz H.T., Palacios I., et al. The results of transvenous endomyocardial biopsy can frequently be used to diagnose myocardial diseases in patients with idiopathic heart failure. Endomyocardial biopsies in 100 consecutive patients revealed a substantial incidence of myocarditis. Circulation 69 (1984) 93-101
63. Cassling R.S., Linder J., Sears T.D., et al. Quantitative evaluation of inflammation in biopsy specimens from idiopathically failing or irritable hearts: experience in 80 pediatric and adult patients. Am Heart J 110 (1985) 713-720
64. Wojnicz R., Nowalany-Kozielska E., Wodniecki J., et al. Immunohistological diagnosis of myocarditis. Potential role of sarcolemmal induction of the MHC and ICAM-1 in the detection of autoimmune mediated myocyte injury. Eur Heart J 19 (1998) 1564-1572
65. Wojnicz R., Nowalany-Kozielska E., Wojciechowska C., et al. Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation 104 (2001) 39-45
66. Baboonian C., and Treasure T. Meta-analysis of the association of enteroviruses with human heart disease. Heart 78 (1997) 539-543
67. Duncan B.W., Hraska V., Jonas R.A., et al. Mechanical circulatory support in children with cardiac disease. J Thorac Cardiovasc Surg 117 (1999) 529-542
68. Hetzer R., Loebe M., Potapov E.V., et al. Circulatory support with pneumatic paracorporeal ventricular assist device in infants and children. Ann Thorac Surg 66 (1998) 1498-1506
69. Levi D., Marelli D., Plunkett M., et al. Use of assist devices and ECMO to bridge pediatric patients with cardiomyopathy to transplantation. J Heart Lung Transplant 21 (2002) 760-770
70. McMahon A.M., van D.C., Burch M., et al. Improved early outcome for end-stage dilated cardiomyopathy in children. J Thorac Cardiovasc Surg 126 (2003) 1781-1787
71. Rosenthal D., Chrisant M.R., Edens E., et al. International Society for Heart and Lung Transplantation: Practice guidelines for management of heart failure in children. J Heart Lung Transplant 23 (2004) 1313-1333
72. Nigro G., Bastianon V., Colloridi V., et al. Human parvovirus B19 infection in infancy associated with acute and chronic lymphocytic myocarditis and high cytokine levels: report of 3 cases and review. Clin Infect Dis 31 (2000) 65-69
73. Tedeschi A., Airaghi L., Giannini S., et al. High-dose intravenous immunoglobulin in the treatment of acute myocarditis. A case report and review of the literature. J Intern Med 251 (2002) 169-173
74. Drucker N.A., Colan S.D., Lewis A.B., et al. Gamma-globulin treatment of acute myocarditis in the pediatric population. Circulation 89 (1994) 252-257
75. McNamara D.M., Rosenblum W.D., Janosko K.M., et al. Intravenous immune globulin in the therapy of myocarditis and acute cardiomyopathy. Circulation 95 (1997) 2476-2478
76. McNamara D.M., Holubkov R., Starling R.C., et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation 103 (2001) 2254-2259
77. Robinson J., Hartling L., Vandermeer B., et al. Intravenous immunoglobulin for presumed viral myocarditis in children and adults. Cochrane Database Syst Rev 1 (2005) CD004370
78. Burch M. Immune suppressive treatment in paediatric myocarditis: still awaiting the evidence. Heart 90 (2004) 1103-1104
79. Camargo P.R., Snitcowsky R., da Luz P.L., et al. Favorable effects of immunosuppressive therapy in children with dilated cardiomyopathy and active myocarditis. Pediatr Cardiol 16 (1995) 61-68
80. Tomioka N., Kishimoto C., Matsumori A., et al. Effects of prednisolone on acute viral myocarditis in mice. J Am Coll Cardiol 7 (1986) 868-872
81. Herzum M., Huber S.A., Weller R., et al. Treatment of experimental murine Coxsackie B3 myocarditis. Eur Heart J 12 Suppl D (1991) 200-202
82. Pauksen K., Ilback N.G., Friman G., et al. Therapy of coxsackie virus B3-induced myocarditis with WIN 54954 in different formulations. Scand J Infect Dis Suppl 88 (1993) 125-130
83. Rotbart H.A. Antiviral therapy for enteroviral infections. Pediatr Infect Dis J 18 (1999) 632-633
84. Kishimoto C., Crumpacker C.S., and Abelmann W.H. Ribavirin treatment of murine coxsackievirus B3 myocarditis with analyses of lymphocyte subsets. J Am Coll Cardiol 12 (1988) 1334-1341
85. Miric M., Vasiljevic J., Bojic M., et al. Long-term follow up of patients with dilated heart muscle disease treated with human leucocytic interferon alpha or thymic hormones initial results. Heart 75 (1996) 596-601
86. Kuhl U., Pauschinger M., Schwimmbeck P.L., et al. Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 107 (2003) 2793-2798